| Literature DB >> 30706191 |
Hiroki Yamamoto1, Masazumi Saito2, Tsuyoshi Goto1, Keiichiro Ueshima1, Masashi Ishida1, Shigeki Hayashi1, Kazuya Ikoma1, Osam Mazda3, Toshikazu Kubo1.
Abstract
Glucocorticoids and hypoxia is considered to promote osteocyte apoptosis and necrosis, which are observed in glucocorticoid-associated osteonecrosis and osteoporosis. Heme oxygenase-1 (HO-1) induced by hemin is reported to have cytoprotective effects in ischemic diseases. The objective of this study was to evaluate the effect of HO-1 on osteocyte death caused by glucocorticoids and hypoxia. We confirmed that hemin induced HO-1 expression in MLO-Y4 mouse osteocytes. MLO-Y4 was cultured with dexamethasone (Dex) under hypoxia (DH group). Furthermore, these cells were cultured with hemin (DH-h group) or hemin and zinc protoporphyrin IX (an HO-1 inhibitor) (DH-h-PP group). The rates of apoptosis and necrosis of these groups were analyzed by flow cytometry and compared with cells cultured under normal condition. Both apoptosis and necrosis increased in the DH group. Hemin administration significantly reduced cell death caused by glucocorticoids and hypoxia in the DH-h group, and its effect was attenuated by the HO-1 inhibitor in DH-h-PP group. Capase-3 activity significantly decreased in the DH-h group. This implied that the cell death inhibition effect due to hemin is mediated by HO-1 and caspase-3. HO-1 induction may be useful in the treatment of glucocorticoid-associated osteonecrosis and osteoporosis.Entities:
Keywords: Heme oxygenase-1; Hemin; Hypoxia; Osteonecrosis of the femoral head; Osteoporosis
Mesh:
Substances:
Year: 2019 PMID: 30706191 DOI: 10.1007/s00795-018-00215-0
Source DB: PubMed Journal: Med Mol Morphol ISSN: 1860-1499 Impact factor: 2.309